1000/1000
Hot
Most Recent
The surgical extraction of the lower third molars is widely practiced in oral surgery. Subsequent inflammatory complications such as pain, facial swelling, and trismus can negatively affect the quality of life of the patients. Non-medication methods used to minimize tissue injury after third-molar extraction and without side effects include the use of photobiomodulation.
Authors and Year of Publication | Laser Properties | Outcomes | Sample Size | |||
---|---|---|---|---|---|---|
(nm) | (mW) | (J/cm2) | ||||
Asutay et al. (2018)[16] | 810 | 300 | 4 | pain, trismus, swelling | 45 | |
Hamid et al. (2017)[17] | 810 | 100 | 32, 86 | pain | 30 | |
Landucci et al. (2016)[18] | 780 | 10 | 7, 5 | pain, trismus, swelling | 22 | |
Sierra et al. (2015)[19] | 660, 808 | 100 | 106 | pain | 60 | |
Sierra et al. (2016)[20] | 660, 808 | 100 | 106 | pain | 60 | |
Pol et al. (2016)[21] | 650, 904 | 8–500, 70 | no reported | pain, swelling | 25 | |
Abdel-Alim et al. (2015)[22] | 830 | 4 | no reported | pain, trismus, swelling | 80 | |
Fabre et al. (2015)[23] | 660 | 35 | 5 | pain, trismus, swelling | 10 | |
Merigo et al. (2015)[24] | 650, 910 | no reported | 480, 31 | pain, swelling | 59 | |
Ferrante et al. (2013)[25] | 980 | 300 | no reported | pain, trismus, swelling | 30 | |
Koparal et al. (2018)[26] | 810 | 300 | 4 | pain, trismus, swelling | 45 | |
Raisesian et al. (2017)[27] | 980 | 300 | 18 | pain, trismus, swelling | 44 | |
Petrini et al. (2017)[28] | 980 | 300 | no reported | pain, trismus, swelling | 45 | |
Kahraman et al. (2017)[29] | 830 | 100 | 3 | pain | 53 | |
Alan et al. (2016)[30] | 810 | 300 | 4 | pain, trismus, swelling | 15 | |
Eroglu et al. (2016)[31] | 940 | no reported | 4 | pain, trismus, swelling | 35 | |
Eshghpour et al. (2016)[32] | 660 | 200 | 85, 7 | pain, swelling | 40 | |
Kazancioglu et al. (2014)[33] | 808 | 100 | 4 | pain, trismus, swelling | 60 | |
Tuk et al. (2017)[34] | 660 | 198 | 67,5 | pain | 163 | |
Farhadi et al. (2017)[35] | 550 | 100 | 5 | pain, trismus, swelling | 48 | |
Pedreira et al. (2016)[36] | 808 | no reported | 2 | pain, trismus, swelling | 24 | |
Lopez Ramirez et al. (2012)[37] | 810 | 500 | 5 | pain, trismus, swelling | 20 | |
Amarillas et al. (2010)[38] | 810 | c100 | 4 | pain, trismus, swelling | 30 | |
Roynesdal et al. (1993)[39] | 830 | 40 | no reported | pain, trismus, swelling | 25 | |
Fernando et al. (1993)[40] | 830 | 30 | no reported | pain, swelling | 52 | |
Markovic et al. (2007)[41] | 637 | 50 | 4 | swelling | 120 | |
Aras et al. (2009)[42] | 808 | 100 | 4 | swelling, trismus | 32 | |
Aras et al. (2010)[43] | 808 | 100 | 4 | swelling, trismus | 48 | |
Feslihan et al. (2019)[44] | 810 | 300 | 6 | pain, trismus, swelling | 30 | |
Santos et al. (2020)[45] | 780 | 70 | 52, 5 | pain | 32 | |
Lakshmi et al. (2021)[46] | 980 | 300 | no reported | pain, trismus, swelling | 100 | |
El Saeed et al. (2020)[47] | 980 | 500 | 4 | pain, trismus, swelling | 20 | |
Nejat et al. (2021)[48] | 660, 980 | 200 | 1.5, 6 | pain | 80 | |
Kamal et al. (2021)[49] | 980 | 100 | no reported | pain, trismus, swelling | 24 | |
Bianchi de Moraes et al. (2020)[50] | 660 | 30 | 10, 30 | pain, trismus, swelling | 57 | |
Kumar Gulia et al. (2021)[51] | 940 | 500 | 10 | pain, trismus, swelling | 32 | |
Scarano et al. (2021)[52] | 1064 | 1000 | no reported | pain, swelling | 20 | |
Momeni et al. (2021)[53] | 940 | 500 | 10 | pain, trismus, swelling | 25 | |
Hadad et al. (2021)[54] | 810 | 100 | 212 | pain, trismus, swelling | 13 | |
Fraga et al. (2020)[55] | 808 | 100 | 133 | pain, swelling | 40 | |
Mohajerani et al. (2020)[56] | 810, 632 | 500 | 5, 2 | pain, trismus, swelling | 40 |
Method of Evaluation | Comparison | Results | |||
---|---|---|---|---|---|
Pain | Swelling | Trismus | |||
[16] | VAS, MO, 3dMD FP | vs. placebo | Reduction | Not statistically significant | Not statistically significant |
[17] | VAS | vs. placebo | Reduction | ||
[18] | VAS, NRS | vs. placebo | Not statistically significant | Reduction | Reduction |
[19] | VAS, FDM, MO | vs. placebo | Reduction | ||
[20] | FDM, MO | 808 nm vs. 660 nm | 808 Reduction | 808 Reduction | |
[21] | VAS, FDM | vs. placebo | Reduction | Reduction | |
[22] | MO, Bello’s FSA | vs. delayed PBM | Reduction | Reduction | Reduction |
[23] | VAS, FDM, MO | vs. placebo | Reduction | Reduction | Reduction |
[24] | VAS, FDM | vs. placebo | Reduction | Reduction | |
[25] | VAS, FDM, MO | vs. placebo | Reduction | Reduction | Reduction |
[26] | VAS, MO, 3dMD FP | vs. placebo | Reduction | Not statistically significant | Not statistically significant |
[27] | VAS, FDM, MO | vs. drug therapy | Reduction | Not statistically significant | Not statistically significant |
[28] | VAS, FDM, MO | vs. drug therapy | Reduction | Reduction | Not statistically significant |
[29] | VAS | intraoral vs. extraoral | Reduction | ||
[30] | VAS, MO, 3dMD FP | vs. placebo | Reduction | Not statistically significant | Not statistically significant |
[31] | VAS, FDM, MO | vs. placebo | Not statistically significant | Not statistically significant | Not statistically significant |
[32] | VAS, ECE | vs. placebo | Reduction | Reduction | |
[33] | VAS, FDM, MO | vs. ozone therapy | Reduction | Reduction | Reduction |
[34] | HR, SR, Questionnaire | vs. placebo | Not statistically significant | ||
[35] | VAS, FDM, MO | vs. placebo | Not statistically significant | Not statistically significant | Not statistically significant |
[36] | VAS, FDM, MO | vs. placebo | Not statistically significant | Not statistically significant | Not statistically significant |
[37] | VAS, FDM, MO | vs. placebo | Not statistically significant | Not statistically significant | Not statistically significant |
[38] | VAS, FDM, MO | vs. placebo | Not statistically significant | Not statistically significant | Not statistically significant |
[39] | VAS, FS, MO | vs. placebo | Not statistically significant | Not statistically significant | Not statistically significant |
[40] | VAS, Swelling scale | vs. placebo | Not statistically significant | Not statistically significant | |
[41] | FDM | vs. placebo | Reduction | ||
[42] | Amin Laskin FS, MO | vs. placebo | Reduction | Reduction | |
[43] | Amin Laskin FS, MO | intraoral vs. extraoral | Reduction | Reduction | |
[44] | VAS, FDM, MO | vs. methylprednisolone | Not statistically significant | Not statistically significant | Not statistically significant |
[45] | VAS | vs. split mouth | Reduction | ||
[46] | VAS, FS, MO | vs. placebo | Not statistically significant | Reduction | Reduction |
[47] | VAS, FS, MO | vs. placebo | Reduction | Reduction | Reduction |
[48] | VAS | vs. placebo | Reduction | ||
[49] | VAS, FS, MO | vs placebo | Reduction | Reduction | Reduction |
[50] | VAS, MO, 3dMD FP | 10 J/cm2 vs. 30 J/cm2 vs. placebo | Not statistically significant | Not statistically significant | Not statistically significant |
[51] | VAS, FS, MO | vs. placebo | Reduction | Not statistically significant | Not statistically significant |
[52] | VAS, FS | vs. placebo | Reduction | Reduction | |
[53] | VAS, FS, MO | vs. placebo | Reduction | Not statistically significant | Not statistically significant |
[54] | VAS, FS, MO | vs. placebo | Reduction | Reduction | Not statistically significant |
[55] | VAS, FS | LLLT + aPDT vs. placebo | Reduction | Not statistically significant | |
[56] | VAS, FS, MO | vs. split mouth | Reduction | Reduction | Not statistically significant |